CD101

CD101 molecule, the group of I-set domain containing|V-set domain containing|CD molecules

Basic information

Region (hg38): 1:117001750-117036552

Previous symbols: [ "IGSF2" ]

Links

ENSG00000134256NCBI:9398OMIM:604516HGNC:5949Uniprot:Q93033AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CD101 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD101 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
2
clinvar
5
missense
56
clinvar
3
clinvar
7
clinvar
66
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
non coding
0
Total 0 0 57 6 9

Variants in CD101

This is a list of pathogenic ClinVar variants found in the CD101 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-117001825-G-A not specified Uncertain significance (Nov 15, 2021)2261814
1-117009952-A-G not specified Uncertain significance (Dec 13, 2022)2334168
1-117010068-C-T not specified Uncertain significance (Jan 24, 2024)3140265
1-117010075-G-A not specified Likely benign (Jun 22, 2021)2234362
1-117010116-G-A not specified Uncertain significance (Jul 12, 2023)2611052
1-117010183-C-A not specified Uncertain significance (May 11, 2022)2392542
1-117010186-A-G not specified Uncertain significance (Dec 19, 2023)3140267
1-117011696-G-A not specified Uncertain significance (Oct 19, 2021)2386083
1-117011711-A-G not specified Uncertain significance (Apr 13, 2022)2283539
1-117011771-C-T not specified Uncertain significance (Dec 26, 2023)3140268
1-117011799-A-G Benign (Feb 23, 2021)1280460
1-117011856-A-G not specified Uncertain significance (Mar 02, 2023)2470236
1-117011864-C-A not specified Uncertain significance (Jan 20, 2023)2476321
1-117011869-C-A not specified Uncertain significance (Dec 13, 2021)2266668
1-117011913-T-A not specified Uncertain significance (Jan 17, 2024)3140269
1-117011959-G-C not specified Uncertain significance (Dec 14, 2023)3140270
1-117013503-A-G Likely benign (May 08, 2018)738561
1-117013639-G-A not specified Uncertain significance (Apr 04, 2023)2507736
1-117013649-T-C Benign (May 16, 2018)728107
1-117013720-C-T not specified Uncertain significance (Apr 19, 2024)3264697
1-117013724-C-A not specified Uncertain significance (Oct 18, 2021)2255560
1-117013754-A-G not specified Uncertain significance (Aug 16, 2022)3140254
1-117017147-C-T not specified Uncertain significance (Apr 22, 2022)2285137
1-117017258-A-T not specified Uncertain significance (Mar 15, 2023)2508423
1-117017402-C-G not specified Uncertain significance (Jan 04, 2022)2353643

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CD101protein_codingprotein_codingENST00000256652 934786
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.28e-130.97212545002981257480.00119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3605285520.9570.00002916644
Missense in Polyphen117131.430.890221657
Synonymous0.2922172230.9750.00001242022
Loss of Function2.352743.80.6160.00000202518

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002390.00239
Ashkenazi Jewish0.000.00
East Asian0.001310.00131
Finnish0.003420.00342
European (Non-Finnish)0.0009360.000932
Middle Eastern0.001310.00131
South Asian0.0003920.000392
Other0.002280.00228

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role as inhibitor of T-cells proliferation induced by CD3. Inhibits expression of IL2RA on activated T-cells and secretion of IL2. Inhibits tyrosine kinases that are required for IL2 production and cellular proliferation. Inhibits phospholipase C-gamma-1/PLCG1 phosphorylation and subsequent CD3- induced changes in intracellular free calcium. Prevents nuclear translocation of nuclear factor of activated T-cell to the nucleus. Plays a role in the inhibition of T-cell proliferation via IL10 secretion by cutaneous dendritic cells. May be a marker of CD4(+) CD56(+) leukemic tumor cells. {ECO:0000269|PubMed:11093127, ECO:0000269|PubMed:15737213, ECO:0000269|PubMed:7722299, ECO:0000269|PubMed:9233604, ECO:0000269|PubMed:9389317, ECO:0000269|PubMed:9647226}.;
Pathway
Generation of second messenger molecules;TCR signaling;Immune System;Adaptive Immune System (Consensus)

Recessive Scores

pRec
0.162

Intolerance Scores

loftool
0.624
rvis_EVS
1.68
rvis_percentile_EVS
96.34

Haploinsufficiency Scores

pHI
0.128
hipred
N
hipred_score
0.123
ghis
0.392

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cd101
Phenotype
immune system phenotype; hematopoietic system phenotype;

Gene ontology

Biological process
positive regulation of myeloid leukocyte differentiation;cell surface receptor signaling pathway
Cellular component
plasma membrane;integral component of membrane;extracellular exosome
Molecular function
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides